In News
glob image
glob image

Cadila Launches Tarzed For Early-stage Breast Cancer

24th Jan, 2022 | News

Cadila Pharmaceuticals has launched trastuzumab under the brand name Tarzed. It is a humanized monoclonal antibody and is recommended for HER2-positive early-stage breast cancer and metastatic breast cancer.

Navjeevan Express
seacrh icon

Navjeevan Express

India News Republic
seacrh icon

India News Republic

Health Vision
seacrh icon

Health Vision

Free Express
seacrh icon

Free Express

ET Healthworld
seacrh icon

ET Healthworld

ET Express Pharma
seacrh icon

ET Express Pharma

Bio Voice
seacrh icon

Bio Voice

Prabhat
seacrh icon

Prabhat

Suger Mint
seacrh icon

Suger Mint

Array
(
    [PHPSESSID] => 4b0a9afdf41f71bdcb0ec64bbb3156c3
    [care_did] => d91abfb8-e500-4437-86f8-e1dc3f47a86c
)